Sanofi Intrinsic Value
SANOFI • Healthcare
Current Stock Price
₹3381.50
Primary Intrinsic Value
₹4566.32
Market Cap
₹7777 Cr
-19.3%
Downside
Median Value
₹2728.48
Value Range
₹749 - ₹4566
Assessment
Trading Above Median Value
Safety Margin
-23.9%
SANOFI Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹4566.32 | ₹3653.06 - ₹5479.58 | +35.0% | EPS: ₹207.56, Sector P/E: 22x |
| Book Value Method | asset | ₹748.70 | ₹673.83 - ₹823.57 | -77.9% | Book Value/Share: ₹374.35, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1874.78 | ₹1687.30 - ₹2062.26 | -44.6% | Revenue/Share: ₹937.39, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹3043.48 | ₹2739.13 - ₹3347.83 | -10.0% | EBITDA: ₹700.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹2728.48 | ₹2182.78 - ₹3274.18 | -19.3% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1328.38 | ₹1195.54 - ₹1461.22 | -60.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹3206.80 | ₹2886.12 - ₹3527.48 | -5.2% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹3339.13 | ₹3005.22 - ₹3673.04 | -1.3% | ROE: 55.7%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1014.45 | ₹913.01 - ₹1115.90 | -70.0% | EPS: ₹207.56, BVPS: ₹374.35 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
SANOFI Intrinsic Value Analysis
What is the intrinsic value of SANOFI?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sanofi (SANOFI) is ₹2728.48 (median value). With the current market price of ₹3381.50, this represents a -19.3% variance from our estimated fair value.
The valuation range spans from ₹748.70 to ₹4566.32, indicating ₹748.70 - ₹4566.32.
Is SANOFI undervalued or overvalued?
Based on our multi-method analysis, Sanofi (SANOFI) appears to be trading above median value by approximately 19.3%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 35.22 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 55.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 32.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.34x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Sanofi
Additional stock information and data for SANOFI
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹462 Cr | ₹372 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹230 Cr | ₹230 Cr | Positive Free Cash Flow | 8/10 |